-
SABCS 2024 | Dr. Yan Xue: The SONIA Trial Reveals No Significant Difference in HRQoL Between First-Line and Second-Line Use of CDK4/6 Inhibitors in Advanced Breast Cancer
At the 2024 San Antonio Breast Cancer Symposium (SABCS), a study led by Professor Noor Wortelboer from Erasmus University Medical Center in Rotterdam was presented during the “Poster Spotlight 2: Personalizing CDK 4/6 Inhibitor Therapy for Patients with Metastatic Breast Cancer: Survival, QOL, and Biomarkers” session. This research, based on the SONIA trial data, provided…
-
SABCS 2024 | Dr. Guojun Zhang: Advances in Tumor Genetics and Targeted Drug Development
The 47th San Antonio Breast Cancer Symposium (SABCS) recently concluded successfully in San Antonio, USA. SABCS is the world’s largest conference in the field of breast cancer, attracting more than 10,000 registered participants from 102 countries. Over four days, the conference featured thousands of keynote speeches and research abstracts. On December 11, during the second…
-
2024 Cross-Strait Breast Cancer Forum | Dr. Jian Liu: Building Bridges for Academic Exchange and Exploring New Pathways in Breast Cancer Treatment
The “2024 Cross-Strait Breast Cancer Forum,” held alongside the 2024 Academic Annual Meeting of the Breast Disease Branch of the Fujian Medical Association, the 2024 Annual Meeting of the Oncology Physicians Branch of the Fujian Medical Doctor Association, and the Fujian Breast Cancer Prevention and Treatment Workshop, took place from December 13 to 15, 2024,…
-
AASLD Exclusive Interview with Dr. Jiangao Fan: New Insights and Advances in Fatty Liver Disease
Key Advances and Trends in MAFLD at AASLD 2023 Hepatology Digest: What are the latest developments and trends in MAFLD research presented at this year’s AASLD? Dr. Jiangao Fan: The…
-
SABCS 2024 | Dr. Jiong Wu: Exploring a New Era in Breast Cancer Treatment – In-depth Analysis and Future Perspectives from SABCS
At the recent San Antonio Breast Cancer Symposium (SABCS), Dr. Jiong Wu from Fudan University Shanghai Cancer Center and his team presented several significant research findings, offering new insights into breast cancer treatment.
-
SABCS2024 | Dr. Xiaojia Wang: New PD-1/VEGF Bispecific Antibody and ADC Introduce Novel Strategies, Multiple RWS Provide Key Insights for Comprehensive Breast Cancer Management
The 47th San Antonio Breast Cancer Symposium (SABCS) was grandly held from December 10–13, 2024, in San Antonio, USA, showcasing significant global advancements in breast cancer research. During the conference, Dr. Xiaojia Wang from the Cancer Hospital of the University of the Chinese Academy of Sciences (Zhejiang Cancer Hospital) presented several important research findings. These…
-
SABCS 2024 | Dr. Yiding Chen Interprets the INSEMA Study: New Evidence for Axillary Surgery De-escalation
The de-escalation strategy for axillary management in breast cancer has been a consistent research focus in breast surgery. Last year, the SOUND study explored whether certain low-risk patients undergoing breast-conserving surgery could avoid sentinel lymph node biopsy (SLNB). At the 2024 San Antonio Breast Cancer Symposium (SABCS), the INSEMA study, a similar investigation, was presented.…
-
Dr. Qiang Liu: Addressing Young Breast Cancer Patients and Exploring Innovations in Diagnosis, Treatment, and Recovery | 2024 Yixian Breast Cancer Conference
The “2024 Yixian Breast Cancer Conference and the Second China Young Breast Cancer Consensus Conference” took place in Guangzhou from December 27 to 28, 2024. The conference explored cutting-edge topics such as the evolving epidemiology of young breast cancer, screening strategies, the impact of genetic mutations, treatment, and recovery approaches. Highlights included the release of…
Connecting Medical Expertise through Media